Home Company Technology Alliances News Contact

 

Press Releases
BioSeek in the News
Scientific Publications
Presentations

Contacts

Media

Shannon Richey
Director of Marketing
313.263.0960                 shannon.richey@asterand.com

Scientific

Ellen Berg, Ph.D.
Chief Scientific Officer
BioSeek, Inc.
650.888.0902
ellen.berg@asterand.com
Business Development

Ivan Plavec, Ph.D.
Vice President Business Development
BioSeek, Inc.
650.416.7629
ivan.plavec@asterand.com


Press Releases

2012 | 2011 | 2009 | 2008 | 2007 | 2006 and prior

2010

Dec. 9

Asterand To Settle Final Payment For Bioseek Acquisition With Cash

Nov. 3

Interim Management Statement

Sept. 23

Asterand's Subsidiary BioSeek Signs Agreement with Cellzome

Sept. 22

Dalia Cohen Ph.D. Joins Asterand as Chief Scientific Officer

August 26

Asterand Releases Interim Report

August 16

Notification of Interim Results

June 14

Asterand Signs Agreement with Amylin Pharmaceuticals

June 9

Annual General Meeting Statement

June 9

View Annual General Meeting Presentation

June 7

PA Extends Asterand's Role in ToxCastTM Program

May 13

Interim Management Statement

May 10

Asterand Board Change

May 4

Asterand Signs Agreement with Eisai Co., Ltd

March 23

Asterand's Subsidiary Bioseek and Ono Initiate New Multi-Year Drug Discovery Collaboration

March 3

Notification of Preliminary Results

February 18

Asterand Completes Acquisition of BioSeek

January

Chemical Target and Pathway Toxicity Mechanisms Defined In Primary Human Cell Systems